Annexon Inc. Common Stock (ANNX)
Stock · NASDAQ · Health Care
$3.42as of 10/16/2026
Price chart
Active signals
ANNX Signal Track Record
How signals performed across all stocks →What ANNX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 44 | +4.4% | 52% | September 16, 2026 |
| Bollinger Band Breakout | 25 | -0.5% | 48% | July 6, 2026 |
| Bollinger Band BreakdownActive now | 19 | -5.8% | 47% | September 8, 2026 |
| 200-Day Moving Average TouchActive now | 9 | +6.6% | 67% | August 13, 2026 |
| Any 20-session window (baseline) | +1.9% | 53% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ANNX
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company provides Tanruprubart, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial fo…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 92
- Website
- annexonbio.com/
Fundamentals
- 1-day range
- $3.36$3.61
- Market cap
- $917.52M
- P/E (trailing)
- —
- P/E (forward)
- -3.15
- EPS (trailing)
- $-1.15
- Dividend yield
- —
- Beta
- 1.40
- Avg. volume
- 2.87M
Forecasts
7 analyst ratings
Annexon Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ANNXAnnexon Inc. Common Stock$3.41▼ 5.28%Market cap $917.52MP/E —$2.54$7.18
- ABUSArbutus Biopharma Corporation Common Stock$4.22▼ 1.63%Market cap $896.82MP/E 5.55$3.5$5.45
- COLLCollegium Pharmaceutical Inc. Common Stock$23.19▲ 0.04%Market cap $944.15MP/E 15.18$21.43$50.79
- OMEROmeros Corporation Common Stock$16.2▼ 13.78%Market cap $951.74MP/E 10.87$4.06$21.24
- AMPHAmphastar Pharmaceuticals Inc. Common Stock$25.87▼ 2.08%Market cap $873.48MP/E 14.15$16.65$29.52
- DSGNDesign Therapeutics Inc. Common Stock$10.31▼ 1.62%Market cap $861.75MP/E —$5.28$17.25
- JANXJanux Therapeutics Inc. Common Stock$16.51▼ 4.68%Market cap $981.85MP/E —$12.12$35.34
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ANNX Annexon Inc. Common Stock | $917.52M | — | $3.41 | ▼ 5.28% | $2.54$7.18 |
| ABUS Arbutus Biopharma Corporation Common Stock | $896.82M | 5.55 | $4.22 | ▼ 1.63% | $3.5$5.45 |
| COLL Collegium Pharmaceutical Inc. Common Stock | $944.15M | 15.18 | $23.19 | ▲ 0.04% | $21.43$50.79 |
| OMER Omeros Corporation Common Stock | $951.74M | 10.87 | $16.2 | ▼ 13.78% | $4.06$21.24 |
| AMPH Amphastar Pharmaceuticals Inc. Common Stock | $873.48M | 14.15 | $25.87 | ▼ 2.08% | $16.65$29.52 |
| DSGN Design Therapeutics Inc. Common Stock | $861.75M | — | $10.31 | ▼ 1.62% | $5.28$17.25 |
| JANX Janux Therapeutics Inc. Common Stock | $981.85M | — | $16.51 | ▼ 4.68% | $12.12$35.34 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga · 10/9/2026
- JP Morgan Maintains Overweight on Annexon, Raises Price Target to $15benzinga · 9/30/2026
- JP Morgan Maintains Overweight on Annexon, Raises Price Target to $15Benzinga · 9/30/2026
- Annexon: Preserving Patient Function Is The Real Investment OpportunitySeekingAlpha · 9/27/2026
- Annexon to Present Patient Baseline Characteristics from Vonaprument Phase 3 ARCHER II Pivotal Trial for Geographic Atrophy at The Retina Society 59th Annual Scientific MeetingYahoo · 9/24/2026
- Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)Yahoo · 9/16/2026
Insider Activity
Insider Actions →- Love Douglas · September 24, 2026 · Buy26.1K @ $3.83
- Blumenkranz Mark S. · August 10, 2026 · Grant175.0K
- William H. Carson · June 11, 2026 · Grant65.0K
- Cockroft Bettina M. · June 11, 2026 · Grant65.0K
- Ted Yednock · June 11, 2026 · Option Exercise30.6K @ $1.85
- Jung Choi · June 11, 2026 · Grant65.0K
- William D. Waddill · June 11, 2026 · Grant65.0K
- JONES WILLIAM A JR · June 11, 2026 · Grant65.0K
- Muneer A. Satter · June 11, 2026 · Grant65.0K
- Muneer A. Satter · May 28, 2026 · Buy613.5K @ $5.41
- William H. Carson · May 11, 2026 · Buy8.0K @ $5.78
Institutional Ownership
March 31, 2026
- Total shares held
- 154.11M
- Total value held
- $845.78M
- Institutional holders
- 210
- Unknown14.55M
- Unknown10.94M
- Unknown10.64M
- Unknown8.70M
- Unknown6.92M
- Unknown5.96M
- Unknown5.21M
- Unknown5.16M
- Unknown4.72M
- Unknown4.30M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
ANNX Listed Among Health Care Stocks Moving Pre-Market
Annexon Inc. was included in a list of health care stocks showing movement during Friday's pre-market session. The stock is currently trading near its 52-week low, with technical signals indicating a breakdown below the Bollinger Bands. Analysts maintain a wide range of price targets, reflecting uncertainty about the company's future performance.
ANNX Listed Among Health Care Stocks Moving Pre-Market. Annexon Inc. was included in a list of health care stocks showing movement during Friday's pre-market session. The stock is currently trading near its 52-week low, with technical signals indicating a breakdown below the Bollinger Bands. Analysts maintain a wide range of price targets, reflecting uncertainty about the company's future performance.